FDA.reportPublic FDA data

LANTIDRA 400 ML Injection

RxCUI
2642270
RxNorm name
LANTIDRA 400 ML Injection
Display name
LANTIDRA 400 ML Injection
Full name
LANTIDRA 400 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125734Lantidradonislecel-jujn351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LANTIDRADONISLECELCellTrans Inc.24610d9f-0c5a-4f55-93b3-d456300bfd5d2026-01-13Warnings, Adverse reactionsExact identifier
rxcui: 2642270

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
24610d9f-0c5a-4f55-93b3-d456300bfd5dLANTIDRA 400 ML InjectionPSN3These highlights do not include all the information needed to use LANTIDRA safely and effectively. See full prescribing information for LANTIDRA. LANTIDRA (donislecel-jujn) Suspension for hepatic portal vein infusion Initial U.S. Approval: 202320260113
24610d9f-0c5a-4f55-93b3-d456300bfd5dLantidra 400 ML InjectionSY3These highlights do not include all the information needed to use LANTIDRA safely and effectively. See full prescribing information for LANTIDRA. LANTIDRA (donislecel-jujn) Suspension for hepatic portal vein infusion Initial U.S. Approval: 202320260113
24610d9f-0c5a-4f55-93b3-d456300bfd5d400 ML donislecel-jujn 2500 EIN/ML Injection [Lantidra]SBD3These highlights do not include all the information needed to use LANTIDRA safely and effectively. See full prescribing information for LANTIDRA. LANTIDRA (donislecel-jujn) Suspension for hepatic portal vein infusion Initial U.S. Approval: 202320260113
24610d9f-0c5a-4f55-93b3-d456300bfd5d400 ML Lantidra 2500 EIN/ML InjectionSY3These highlights do not include all the information needed to use LANTIDRA safely and effectively. See full prescribing information for LANTIDRA. LANTIDRA (donislecel-jujn) Suspension for hepatic portal vein infusion Initial U.S. Approval: 202320260113